AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05286970 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AK115
Description: Abdominal subcutaneous injection
Study NCT05286970 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Abdominal subcutaneous injection
Study NCT04995367 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Implementation of a BCI system integrated to the T-FLEX lower-limb exoskeleton in post-stroke patients.
Description: The participants will carry out 4 tasks with a BCI system integrated to the T-FLEX device. The task consists of 1 session that includes 4 conditional experiments: Active ankle movement, passive ankle movement, Motor Imagery Detection with Visual cue, and Motor Imagery Detection with Tactile Stimulation and visual cue.
Study NCT05194085 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: POC viral load testing
Description: POC viral load testing- women randomized to have POC VL at enrollment, delivery and 6 months post-partum, will have a finger prick to obtain whole blood for the Cepheid Xpert HIV-1 RNA cartridge on the Xpert IV machine with results in 90 minutes. Women who are randomized to POC VL who have VL >200 c/ml will receive additional adherence counseling, following the STREAM protocol, \[26\] to address the challenges that they are having with ART use. At the delivery visit, infants of women in the POC VL arm will also have viral load testing done.
Study NCT05194085 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Wellness visit services for male partners
Description: Wellness visits for men- additional prevention services for men randomized to the intervention arm, including dual syphilis and HIV testing, blood pressure, visual acuity screening, and COVID-19 screening as part of wellness
Study NCT06168032 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Any Chinese government-recommended COVID-19 booster vaccine
Description: Any Chinese government-recommended COVID-19 booster vaccine(such as Recombinant COVID-19 Trivalent (XBB+BA.5+Delta) Protein Vaccine(Sf9 Cell) and so on) will be once administered in the sixth month after COVID19 infection.
Study NCT06308276 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Aerobic Training
Description: Aerobic Training: Brisk walking, jogging, cycling, or low-impact aerobics
Study NCT06308276 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Resistance Training
Description: Resistance Training: Full body resistance exercise targeting major muscle groups, including squats, lunges, chest presses, rows, and core exercises
Study NCT06494722 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Diabetes Education
Description: Participants in this arm will receive traditional diabetes education over 5 sessions in the first 3 months of participation and be followed for 6 months.
Study NCT06494722 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: T1DES
Description: Participants in this arm will receive the T1DES behavioral interventions over 5 sessions in the first 3 months of participation and be followed for 6 months.
Study NCT06494319 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Stress NAVIGATOR (Mobile Health Application)
Description: Participants will be prompted to complete their assessments each week (or upon completion of each session) via the Stress NAVIGATOR mobile health app
Study NCT06494319 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: SIT NAVIGATOR
Description: Participants will complete 11 self-paced virtual SIT sessions in the SIT-NAVIGATOR classroom. Participants will be asked to complete at least one session per week, in a minimum of 12 weeks and a maximum of 14 weeks.
Study NCT06494319 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: SIT NAVIGATOR
Description: Participants will complete 11 self-paced virtual SIT sessions in the SIT-NAVIGATOR classroom. Participants will be asked to complete at least one session per week, in a minimum of 12 weeks and a maximum of 14 weeks.
Study NCT06096597 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Clarix Flo
Description: 100 mg of commercially available micronized amniotic membrane (Clarix Flo; BioTissue, Miami, FL) diluted in 10 mL of 0.9% preservative-free sodium chloride
Study NCT06096597 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 10 mL of 0.9% preservative-free sodium chloride
Study NCT05882448 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: laparotomy
Description: Exploratory and therapeutic laparotomy if necessary, in case of necrotic intestine requiring resection with anastomosis or stoma-type bowel diversion
Study NCT05882448 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: laparotomy
Description: Exploratory and therapeutic laparotomy if necessary, in case of necrotic intestine requiring resection with anastomosis or stoma-type bowel diversion
Study NCT05882448 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Laparoscopy
Description: laparoscopy with insufflation of CO2 (placement of a 3mm trocar in the left hypochondrium and insufflation of a pneumoperitoneum (carbon dioxide, pressure: 6 mmHg, flow rate: 1.5 Liter/minute) for a duration of at least 5 minutes.
Study NCT04834622 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Melodies for Mums
Description: Melodies for Mums (M4M) is an intervention that was developed and tested as part of a collaboration between the Royal College of Music, Imperial College London and University College London from 2015-2017. The programme involved weekly singing classes for mothers and their babies delivered in groups of 8-12 in Children's Centres for 10 weeks. A trained artist delivers 1-hour long singing sessions to mothers with postnatal depression (and their babies) for a period of 10-weeks. The sessions are aimed at the mothers, with songs ranging from sound baths to folk songs and songs created by the mothers themselves. Mothers randomised to the intervention will be prompted via text message, each week before the session, to attend these singing sessions.
Study NCT04834622 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Control Community Sessions
Description: Group mother-baby interventions in the community (i.e. baby play, baby reading sessions, baby massage, etc). A list of these activities will be collected from the activities on offer in the community. All the mothers randomised to the control group will be pointed towards these activities, prompted by text messages in line with the prompts received by the mothers in the intervention group. Mothers will be encouraged to attend these non-music based community activities once a week with their babies.
Study NCT05381818 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Daily Inspiratory Muscle Training (dIMT)
Description: Daily IMT training sessions for 2-4 weeks prior to surgery
Study NCT05381818 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Acute Inspiratory Muscle Training (aIMT)
Description: A single session of IMT provided within 30 minutes prior to anesthesia induction.
Study NCT05381818 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard of Care (SOC)
Description: Standard of care only pre and post-operatively.
Study NCT06359509 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: BCMA Targeted CAR T-cells
Description: Each patient will receive BCMA Targeted CAR T-cells by intravenous infusion.
Study NCT06078969 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prednisone
Description: For the experimental group, the patient will be administrated oral prednisone (0.5mg/kg/day, first 5 days per month, 6 months)
Study NCT05137327 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Classroom Behavior Support (CBS) Condition
Description: An individualized teacher consultation program that includes observation and performance feedback and techniques borrowed from Motivational Interviewing and Cognitive Behavioral Therapy (CBS). It is designed to address barriers to implementation and improve teacher practices and student outcomes.
Study NCT05137327 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard Problem Solving Consultation
Description: A standard problem solving approach to teacher consultation that includes observation and brief performance feedback. It represents current best practice in teacher consultation.
Study NCT04612010 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: WAVES (Wobble-oscillator Auditory/Visual Excitatory Stimulation)
Description: An app-based stimulation program administered that provides desynchronizing visual and auditory stimulation. The frequency of the stimulation oscillates around the baseline frequency determined by EEG.
Study NCT04612010 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: WAVES (Wobble-oscillator Auditory/Visual Excitatory Stimulation)
Description: An app-based stimulation program administered that provides desynchronizing visual and auditory stimulation. The frequency of the stimulation oscillates around the baseline frequency determined by EEG.
Study NCT05300178 — intervention group
Intervention type: PROCEDURE
Intervention: coronary artery bypass grafting surgery
Description: Strategies of Complete Arterial Revascularization THE COMPOSITE TECHNIQUE When the distal RIMA bifurcation cannot loosely reach the LAD, we use the RIMA as a free graft, and a T-shaped , or if more suitable, a Y-shaped anastomosis at the level of the main pulmonary artery, is prepared before connection to cardiopulmonary bypass (CPB) THE CROSS TECHNIQUE The cross arrangement is based on the assumption that patency rates of the right internal mammary artery (RIMA) on the left anterior descending coronary artery (LAD) is similar to that of the left internal mammary artery (LIMA) on the LAD. To improve late survival, every effort should be made to use both IMA grafts for the left system THE IN SITU SEQUENCE When a graft to the posterior wall of the heart is not necessary (the circumflex region), the LIMA is grafted to the left anterior descending and the RIMA to the right coronary artery or its posterior de
Study NCT04950257 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: digital CBT self-help including specific intervention elements to target worry and rumination.
Description: The self-help app includes self-monitoring, psychoeducation and active self-help exercises. The self-monitoring includes daily mood ratings and an ecological momentary assessment option (MoodTracker) for more detailed analysis of mood, worry, activity and situational context. The digital self-help provides psychoeducation, tips, advice, exercises and training for each individual focused on reducing worry and rumination, using strategies from the proven rumination-focused CBT intervention. The app includes text, pictures, audio-recordings, animations, audio-exercises to practice (e.g., self-compassion, relaxation, concreteness exercises), and questionnaires with tailored feedback. The app is designed for iOS and Android use.
Study NCT04950257 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: digital CBT self-help including specific intervention elements to target worry and rumination.
Description: The self-help app includes self-monitoring, psychoeducation and active self-help exercises. The self-monitoring includes daily mood ratings and an ecological momentary assessment option (MoodTracker) for more detailed analysis of mood, worry, activity and situational context. The digital self-help provides psychoeducation, tips, advice, exercises and training for each individual focused on reducing worry and rumination, using strategies from the proven rumination-focused CBT intervention. The app includes text, pictures, audio-recordings, animations, audio-exercises to practice (e.g., self-compassion, relaxation, concreteness exercises), and questionnaires with tailored feedback. The app is designed for iOS and Android use.
Study NCT04864665 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: a formula with prebiotics and milk fat
Description: Provided in a formula added with prebiotics and milk fat for 1 month
Study NCT06033820 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ZR2-ICE
Description: * Drug: zanubrutinib Oral Capsule~* Drug: lenalidomide Oral Capsule~* Drug: R-ICE chemotherapy
Study NCT05099861 — intervention group
Intervention type: OTHER
Intervention: No intervention
Description: this is an observational study
Study NCT04938128 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CPAP
Description: Gold standard treatment for obstructive sleep apnea. In this group, patients will be prescribed CPAP treatment according to local policy.
Study NCT05233241 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: in vitro Allergological test Allergological skin tests
Description: In vitro allergological tests: lymphocyte transformation test, measurement of CD154 membrane expression, ELISPOT-IFNgammma Allergological skin tests (patch tests, prick tests and intradermal tests with European standardised method) in case of negative in vitro tests.
Study NCT05726500 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Arterial blood gas analysis
Description: The researches will collect 2 ml of arterial blood using an arterial line already in place for clinical purposes to perform and arterial gas analysis.
Study NCT05726500 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Venous blood gas analysis
Description: The researches will collect 2 ml of arterial blood using a central venous line already in place for clinical purposes to perform a gas analysis.
Study NCT05726500 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Esophageal pressure monitoring
Description: The researchers will position an esophageal balloon to evaluate esophageal pressure
Study NCT05726500 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Intrabdominal pressure
Description: The researches will assess intrabdominal pressure using the urinary catheter system already in place for clinical purposes .
Study NCT05726500 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Electrical impedance tomopgraphy
Description: The researches will evaluate regional ventilation distribution using Electrical impedance tomography at different levels of positive end-expiratory pressure
Study NCT05213377 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Preoperative warming
Description: Patients enrolled in surgery who will not receive 30 minutes of pulsed air thermal blanket warming prior to induction of anesthesia (3M™ Bair Hugger™ Adult Integral Blanket, Model 300 Dimensions: 213 cm x 91 cm)
Study NCT04307992 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Prophylactic sac filling with AneuFix
Description: ANEUFIX is administered by injection into the AAA via transferal access at the time of EVAR placement using imaging techniques to guide the place of injection.
Study NCT06470269 — intervention group
Intervention type: BEHAVIORAL
Intervention: Eye tracking
Description: Recording the eye movement of participants while they read medical cases.
Study NCT05069181 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pilates mat exercises
Description: Pilates mat exercises: Each Pilates session will last for one hour and commence with a 10 minute warm up and finish with a 10 min cool down. The subjects will be taught the 5 key elements of Pilates (lateral costal breathing, centring which is a neutral position of the lumbar spine with activation of the core muscles, ribcage placement, shoulder blade placement and neutral position of the cervical spine with slight upper cervical flexion at the cranio-cervical junction).~Pilates exercise program will consist of warm up exercises, main treatment program (10 level) and cooling down exercises.
Study NCT05069181 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: cervical stabilization exercises
Description: training of deep cervical flexor muscles with pressure biofeedback unit, 20 min/day, 3 days/week for 12 weeks.
Study NCT05069181 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: conventional physiotherapy
Description: 10 min hot pack on cervical area range of motion exercises and isometric neck exercises as a home program 3 days/week for 12 weeks
Study NCT05069181 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: conventional physiotherapy
Description: 10 min hot pack on cervical area range of motion exercises and isometric neck exercises as a home program 3 days/week for 12 weeks
Study NCT04888273 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Transition Intervention
Description: Each adolescent-parent pair will be invited to complete 5 components of the intervention (peer support session, parent education session, transition meeting with healthcare providers, family doctor contact, and reading a transition navigation guide) over a 3-month period. These intervention components were designed with the intention of making the transition process transparent for the duo, preparing the adolescent to take responsibility of their own health as it relates to their disorder, and helping the parent step back from the process to help the adolescent integrate to adult care better.
Study NCT05504733 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Layperson Audiovisual Assist Tourniquet (LAVA TQ)
Description: The Layperson Audiovisual Assist Tourniquet is a hemorrhage control device designed to occlude blood flow in the event of limb hemorrhage. This device provides audiovisual instructions and feedback.
Study NCT05504733 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Layperson Audiovisual Assist Tourniquet (LAVA TQ)
Description: The Layperson Audiovisual Assist Tourniquet is a hemorrhage control device designed to occlude blood flow in the event of limb hemorrhage. This device provides audiovisual instructions and feedback.
Study NCT05504733 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Combat Application Tourniquet
Description: The Combat Application Tourniquet (CAT) is a hemorrhage control device designed to occlude blood blow in the event of a limb hemorrhage. The CAT utilizes a windlass rod design.
Study NCT05504733 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Combat Application Tourniquet
Description: The Combat Application Tourniquet (CAT) is a hemorrhage control device designed to occlude blood blow in the event of a limb hemorrhage. The CAT utilizes a windlass rod design.
Study NCT05070767 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Neurolens spectacle lens
Description: spectacle lens
Study NCT05070767 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Placebo spectacle lens
Description: spectacle lens for refractive error correction
Study NCT04755361 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Housing Outreach Project Collaboration (HOP-C)
Description: HOP-C has several components: HOP-C Case management is outreach-based (emphasizing community and home contacts) and participant goal-driven, providing coaching and skill building in key functional domains and assistance with navigating various systems (justice, housing, employment, health, education). The mental health component has two parts. One is a weekly, 90-minute, mental health and wellness-oriented group. The group acts, for most, as a stepped care approach, with members moving on to access individual psychotherapy as needed. Peer support is provided by youth with a history of lived experience of homelessness who have successfully achieved housing stability and progress in major life domains. Peers receive extensive training and are formally hired into these roles with their being 2-3 peers on the team.
Study NCT05555537 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: MiRNA223 and High mobility group box1(HMGB1)
Description: Measure tye 2 biomarkers miRNA223 and HMGB1 in drug resistant and in medically controled epilepsy
Study NCT04996121 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: XZP-5955 tablets
Description: Phase I dose escalation:~For each dose cohort, XZP-5955 tablet will be administered orally, single dose for day 1 and then from day 4, administered for continuous cycles of 21 consecutive days for each cycle~Phase I dose expansion:~XZP-5955 tablet will be administered orally, once daily for continuous cycles of 21 consecutive days for each cycle. Some patients for PK sample collection, the drug will be administered single dose for day 1, then from day 4, administered for continuous cycles of 21 consecutive days for each cycle~Phase II:~XZP-5955 tablet will be administered orally, once daily for continuous cycles of 21 consecutive days for each cycle
Study NCT05320471 — intervention group
Intervention type: OTHER
Intervention: This is an observational study
Description: This is an observational study
Study NCT05880446 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Bowel symptoms & QoL assessment
Description: QoL and bowel symptoms questionnaires will be held to patients, anthropomorphic measurement, handgrip test, physical activity level and usual diet quality of the patient will be assessed.
Study NCT05850221 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: weight training
Description: weight training
Study NCT04739046 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Theragene arm
Description: Theragene®,Ad5-yCD/ mutTKSR39rep-ADP with radiation therapy